|Slideshows|December 23, 2019

Exploring the Proactive Model

How much do you know about the innovative Proactive Consultation-Liaison (C-L) Psychiatry model? Learn more and test your knowledge in this interactive quiz.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Which Patients Are Less Likely to Believe They Have a Comorbid Mental Health Disorder?

ByMark Zimmerman, MD

May 27th 2026

The Significant Presence of Comorbidities in Bipolar Depression: Insights From Mark Zimmerman, MD

ByMark Zimmerman, MD

May 27th 2026

Intersections of Cardio-Oncology and Psychiatry

ByFrank A. Clark, MD,Mary Branch, MD

April 2nd 2026

Earn CME Credit With Psychiatric Times: Articles You Don’t Want to Miss

ByPsychiatric Times Editors

February 24th 2026

cardiovascular disease psychiatry comorbid

Cardiologists Call for Collaboration on Mental Health of Patients with Cardiovascular Disease

ByKenneth J. Bender, PharmD, MA

February 19th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Exploring the Proactive Model

Related Content

Which Patients Are Less Likely to Believe They Have a Comorbid Mental Health Disorder?

The Significant Presence of Comorbidities in Bipolar Depression: Insights From Mark Zimmerman, MD

Intersections of Cardio-Oncology and Psychiatry

Earn CME Credit With Psychiatric Times: Articles You Don’t Want to Miss

Cardiologists Call for Collaboration on Mental Health of Patients with Cardiovascular Disease

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

Monoamines: A Full House

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

Paying Attention to the Psychopharmacology Pipeline

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings